Dr. Emmalind Aponte
Claim this profileTexas Oncology - San Antonio
Studies Breast Cancer
Studies Breast cancer
11 reported clinical trials
21 drugs studied
Area of expertise
1Breast Cancer
Stage III
Stage IV
HER2
2Breast Cancer
Stage III
Stage IV
BRCA positive
Affiliated Hospitals
Clinical Trials Emmalind Aponte is currently running
Elacestrant
for Breast Cancer
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.
Recruiting2 awards Phase 33 criteria
Bria-IMT + CPI
for Advanced Breast Cancer
This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor [Retifanlimab], versus Treatment of Patients'/Physicians' Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies available.
Recruiting2 awards Phase 36 criteria
More about Emmalind Aponte
Clinical Trial Related7 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Emmalind Aponte has experience with
- Placebo
- Abemaciclib
- MammaPrint
- BluePrint
- Full-Genome Testing
- Breast Cancer Index (BCI) Test
Breakdown of trials Emmalind Aponte has run
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Emmalind Aponte specialize in?
Emmalind Aponte focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage III patients, or patients who are Stage IV.
Is Emmalind Aponte currently recruiting for clinical trials?
Yes, Emmalind Aponte is currently recruiting for 2 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that Emmalind Aponte has studied deeply?
Yes, Emmalind Aponte has studied treatments such as Placebo, Abemaciclib, MammaPrint.
What is the best way to schedule an appointment with Emmalind Aponte?
Apply for one of the trials that Emmalind Aponte is conducting.
What is the office address of Emmalind Aponte?
The office of Emmalind Aponte is located at: Texas Oncology - San Antonio, San Antonio, Texas 78240 United States. This is the address for their practice at the Texas Oncology - San Antonio.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.